CCL22 and metastatic malignant neoplasm in the lymph nodes: The higher number of CCL22+ cells was significantly associated with lymph node metastasis (p < 0.05), FIGO stages (p < 0.05), therapeutic strategies (p < 0.05), and survival status (p < 0.05).